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Summary 
Leukocyte migration from circulation into tissue depends on leukocyte integrin-mediated ad- 
hesion to endothelium, but integrins cannot function until activated. However, it remains to be 
understood how tumor cells  adhere to endothelium and infiltrate into underlying tissue.  We 
studied mechanisms of extravasation of leukemic cells using adult T  cell leukemia (ATL) cells and 
report the following novel features of cell surface heparan sulfate proteoglycan on ATL cells 
in ATL cell adhesion to endothelium:  ATL cells adhere to endothelial cells through already 
activated  integrins  without  exogenous  stimulation;  different  from  any  other  hematopoietic 
cells, ATL cells express a characteristic heparan sulfate capable of immobilizing heparin-binding 
chemokine macrophage inflammatory protein (MIP)-I[3, a potent T  cell integrin trigger, pro- 
duced by the cells themselves; competitive interruption of endogenous heparan sulfate pro- 
teoglycan synthesis reduces cell surface MIP-113 and prevents ATL cells from integrin-medi- 
ated  adhesion  to  endothelial  cells  or  intercellular  adhesion  molecule-1  triggered  through 
G-protein. We propose that leukemic cells  adhere  to endothelial  cells  through  the  adhesion 
cascade, similar to normal leukocyte, and that the cell surface heparan sulfate, particularly on 
ATL cells, is pivotally involved in chemokine-dependent autocrine stimulation ofintegrin trig- 
gering by immobilizing the chemokine on them. 
L 
eukocyte migration from circulation into tissue is un- 
derstood  to  involve,  in  a  coordinated  sequence  of 
events,  stabilizing adhesion molecules both on the leuko- 
cyte and on the endothelium (1-4). The adhesion is medi- 
ated  by leukocyte  integrin  binding  to  endothelial  ligands 
(5).  However,  leukocyte  integrins  cannot  function  until 
they are activated and integrin  triggers are essential to the 
mtegrin-mediated adhesion in which a signal transduced to 
the leukocyte coverts the functionally inactive integrin  to 
an active adhesive configuration  (1,  3).  We have reported 
that the  chemokine macrophage inflammatory protein-l[3 
(MIP-I[3) 1 triggers integrin and induces adhesion ofT cell 
1Abbremations used in this paper: ATL, adult T cell leukemia, FGF, fibro- 
blast growth factor; HEX-D-xyloslde,  hexyl-[3-D-xyloside;  HUVEC, hu- 
man umbahcal vein endothehal cells; ICAM, intercellular adhesion mole- 
cule; MIP-313, macrophage mflarnmatory  protean-l[3; NAP-D-xyloslde, 
(6-hydroxyl)-2-naphthyl-[3-D-xyloside, NAP-c-xyloslde, (6-hydroxyl)- 
2-naphthyl-[3-t-xylosxde. 
subsets to endothelial integrin ligands  (6). Recent papers and 
reviews have supported the potential importance of chemo- 
kines  in  inflammatory responses  that  various  other  chemo- 
kines, as well as MIP-I[3, produced in large amounts from 
inflamed tissues  trigger integrins on leukocytes and mono- 
cytes which leads to their accumulation in the tissues  (4, 7). 
Furthermore,  we  and  others  have  proposed  that  chemo- 
kines MIP-I[3 and IL-8 recruit leukocytes most efficiently 
when immobilized on the luminal surface of endothelium 
and that heparan sulfate proteoglycan on the  endothelium 
immobilize the  chemokines in this process without being 
washed away by the blood flow (6, 8-10). 
Heparan sulfate proteoglycan is posttranslationally modi- 
fied by the  addition  of heparan  sulfate glycosaminoglycan 
side chains made up of long and finear disaccharide subunits 
at serine residues of core protein, some of which .are in the 
extracellular  matrix,  while  others  are  integral  membrane 
proteins  (11,  12).  Various  cytokines  and  growth  factors 
such as all the chemokines, IL-7, GM-CSF, fibroblast  growth 
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heparin-binding sites, which allow these proteins to bind to 
heparan sulfate proteoglycan (13-17). These factors xnteract 
in functionally important ways with heparan sulfate in sev- 
eral contexts:  (a)  extracellular matrix heparan  sulfate pro- 
teoglycan binds these factors such as FGF as a reservoir (18, 
19);  (b) cell surface heparan sulfate interacts with these fac- 
tors, e.g., FGF, to facilitate their binding with the primary 
high affinity receptor on the same cells; and (c) we and others 
have proposed that cell surface heparan sulfate immobilize 
the factors such as GM-CSF and MIP-1[3 and present them 
to  their primary receptor on  another  cell  (6,  17).  Further- 
more, heparan sulfate enhances formation ofcytokine mul- 
timers,  which  facilitates cross-linking of the  cytokine  re- 
ceptors. 
The extravasation of tumor cells which is one important 
step of tumor metastasis is mediated by tumor cell adhesion 
to endothelial cells (20, 21). However, it remains to be un- 
derstood how tumor cells adhere to endothelium and sub- 
sequently  infiltrate  into  underlying  tissue.  We  have  ad- 
dressed the  mechanism  of extravasation  of leukemic  cells 
using adult T  cell leukemia  (ATL)  cells. ATL is a  unique 
and useful model to assess the extravasation, since ATL is a 
peripheral  CD4 +  T  cell  malignancy  caused  by  infection 
with  HTLV-I  and since ATL shows  a  marked increase of 
peripheral ATL  cells with  monoclonal  growth  and  severe 
infiltration into multiple organs in an acute phase  (22-24). 
The present report demonstrates  that heparan sulfate pro- 
teoglycans are abundantly expressed on the surface of ATL 
cells and ATL cell lines, whereas any other hematopoietic 
cells and cell lines which we have screened do not express 
them,  and proposes that the heparan sulfate proteoglycans 
on ATL cells which immobilize integrin-triggering chemo- 
kine in an  autocrine mechanism play a  pivotal role in  the 
continuous  triggering of integrin  and  facilitation of ATL 
cell adhesion to endothelial cells. 
Materials  and Methods 
A TL Cells and A TL Cell Lines.  18  patients  with  ATL  and 
one case of chronic T  cell leukemia which is not infected with 
HTLV-I as a  control, four established HTLV-I-infected T  cell 
lines, MT-1,  MT-2,  HUT-102,  and SALT-3 (from K. Sagawa, 
University of Kurume,  Kurume, Japan,  and  1.  Miyoshi, Koch1 
Medical University, Kochi, Japan) were used. ATL was diagnosed 
according to the clinical features, hematological finchngs,  serum 
antibodies  against  HTLV-I,  and  monoclonal  integration  of 
HTLV-I proviral genome (22, 23). Highly purified CD4 + T cells 
and ATL cells were prepared by exhaustive negative selection (3) 
from PBMC of normal donors and ATL patients using magnetic 
beads  (Dynal,  Oslo,  Norway)  and  multiple-antibody cocktail 
consisting of CD19  mAb  FMC63,  CD16  mAb  3G8,  CD11b 
mAb NIHllb-1, and CD14 mAb 63D3. 
Antibodies and Other Reagents.  The following mAbs were used 
as purified Ig in preparation ofT cells and ATL cells, staining and 
analysis  of cell surface molecules, blocking of cellular adhesion; 
anti-heparan sulfate  mAb HK249  which was locally established 
(25) and 10E4  (Seikagaku Kogyo, Tokyo, Japan), activated LFA-1 
mAb NKI-L16 (C.  Figdor, University Hospital, Nijmegen, Neth- 
erlands)  (26),  CD19  mAb  FMC63  (H.  Zola,  Flindens Medical 
Center,  Bedford  Park,  Australia),  CDllb  mAb  NIHllb-1, 
CD49d (very late antigen [VLA]-4) mAb NIH49d-1, CD54 (m- 
tracellular adhesion molecule [ICAM]-I) mAb 84H10  (S. Shaw, 
National  Inmtutes  of Health  [NIH],  Bethesda,  MD),  CD49d 
mAb HP2/1  (F. Sanchez-Madrid, The Pnncess Hospital, Madrid, 
Spain) (27, 28), CD16 mAb 3G8 (D. Siegel, Bethesda, MD), CD2 
mAb MAR206  (A. Moretta, Umversity of Genova, Genova, It- 
aly),  CD62L  (L-selectin) mAb Leu-8  (Becton Dickinson Japan, 
Tokyo, Japan), CD14 mAb 63D3,  CD11a (LFA-lot) mAb TS1/ 
22,  MHC  class I  mAb W6/32,  control mAb Thyl.2  (ATCC, 
R.ockville, MD). ICAM-1 was purified by affinity column chro- 
matography from the Reed-Sternberg cell hne L428 as previously 
described (3, 29).  (6-hydroxyl)-2-naphthyl-J3-D-xyloside (NAP- 
D-xyloslde) which is a competiuve inhibitor capable of interrupting 
endogenous heparan sulfate- and chondroitin sulfate-proteoglycan 
biosynthesis, its  nonfunctional  isomer  (6-hydroxyl)-2-naphthyl- 
[3-r-xyloside  (NAP-L-xyloside), and  hexyl-J3-D-xyloside  (HEX- 
D-xyloside) which competiuvely interrupts endogenous chondroitm 
sulfate- but not heparan sulfhte--proteoglycan synthesis were de- 
veloped as previously described (30, 31, and manuscript in prepa- 
ration). 
Adhesion Assay.  Adhesion assay of ATL cells and cell lines to 
human umhihcal vein-derived endothelial cells (HUVEC) or pu- 
rified ICAM-1  glycoproteins was  performed  as  previously de- 
scribed (3,  29).  HUVEC  were applied to 48-well culture plates 
(Costar Corp., Cambridge, MA) coated with 2% gelatin and were 
cultured to  confluence m  DMEM  (Nissui, Tokyo, Japan)  con- 
taining  100  U/ml  penicillin G,  100  U/ml  streptomycin,  20% 
heat-inactivated FCS, endothelial mltogen 20 p~g/ml (Biomedical 
Technologies,  Stoughton,  MA)  and  hepann  (10  U/ml).  After 
washing with PBS, HUVEC were stimulated with 1 ng/ml IL-I~ 
(Otsuka,  Tokyo, Japan)  for 4  h  at 37°C.  Purified ICAM-1  (50 
ng/well) was applied to the 48-well plates in Ca/Mg-free PBS at 
4°C  overnight.  Binding sites  on  the  plastic were  subsequently 
blocked with  Ca/Mg-free PBS/3%  HSA (Green-Cross, Osaka, 
Japan)  for 2  h  at  37°C  to  reduce  nonspecific attachment.  The 
plates were washed three times with PBS before the addition of 
T  cells.  2  X  10  s T  cells,  ATL cells,  and ATL cell lines, which 
were  labeled with  51Cr (DuPont  NEN,  Wilmington,  DE)  in 
1KPMI 1640  (Nlssul)  with  1% HSA, were added to the culture 
with or without relevant adhesion-blocking mAb in the presence 
or absence of PMA (10  ng/ml, Sigma Chemical Co., St.  Louis, 
MO)  which is a pharmacologically relevant trigger for integrin 
adhesiveness.  All mAbs were used at a saturating concentration of 
10 Ixg/ml, which was shown in previous studies to maximally in- 
hibit the relevant adhesive interaction (3). After a settling phase of 
30 min at 4°C, which also allowed mAb binding, plates were rap- 
idly warmed to 37°C  for 30 rmn.  Then,  the plates were gently 
washed twice with 1KPMI 1640  at room temperature to remove 
nonadherent T  cells and ATL cells completely. Contents of each 
well containing adherent T  cells  or ATL cells were lysed with 
250 Ixl of 1% Triton X-100 (Sigma), and y emissions of well con- 
tents were determined. Data are expressed as mean percentage of 
binding of indicated cells from a representative experiment. 
Flow Microfluorometry.  Staining and  flow cytometric analyses 
of freshly obtained ATL cells or normal T  cells were carried out 
by standard procedures as already described using a  FACScan  ® 
(Becton Dickinson and Co., Mountain View,  CA)  (3).  Briefly, 
cells (2 X  10  s) were incubated with negative control mAb thyl.2, 
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Figure  1.  Spontaneous adhesion of ATL cells to IL-lJ3- 
activated  HUVEC.  Adhesion of resting  or  PMA-actl- 
vated peripheral  normal CD4 + T cells, ATL cells freshly 
obtained from periphery  of three representauve ATL pa- 
uents,  CD4-posltive  leukermc  cells from  a patient  with 
HTLV-I-negatwe T cell leukemia and four ATL cell lines, 
MT1, MT2, SALT-3, and HUT-102 which were labeled 
with SlCr to  IL-l[3-actwated  HUVEC, was assessed after 
the 30-rmn mcubanon at 37°C. 3' Ermsslons of the lysates 
of only adherent cells were deterrmned. Data are expressed 
as mean percentage  of binding of ln&cated  cells from  a 
representatwe experiment 
L-selectin (CD62L) mAb Leu-8, LFA-1  (CD11a)  mAb TS1/22, 
VLA-4  (CD49d)  mAb  NIH49d-1,  CD2  mAb  MAR206,  acti- 
vated LFA-1  mAb NKI-L16, anti-heparan sulfate mAb HK249 
(25),  or 10E4 in FACS  ® media consisting of HBSS (Nissm, To- 
kyo, Japan), 0.5% HSA, and 0.2% NaN  3 (Sigma)  for 30 min at 
4°C. After washing the cells with FACS  ® media three tunes, the 
cells  were  further  incubated with  FITC-conjugated goat  anu- 
mouse IgG Ab for 30 mm at 4°C. After washing and incubating 
with irrelevant mAbs, the cells were further incubated with CD4- 
PE  (Fujisawa, Osaka, Japan)  for 30 mln at 4°C. The staining of 
cells with the mAbs was detected by the gating on CD4-positive 
cells  using a FACScan  ®. Amplification of the mAb binding was 
provided by a three-decade logarithmic amplifier. 
Northern Blot Analysis.  For Northern blot analysis, total cellu- 
lar RNA was isolated from freshly obtained normal T  cells, ATL 
cells,  and ATL cell lines by using single-step isolation procedure 
(32).  The RNA (10 Ixg) was electrophoresed on 1% agarose gel 
and was blotted onto nylon membrane filters  (Amersham Corp., 
Arlington Heights,  IL).  EcoRI  fragment  of pAT  744  MIP-113 
cDNA  (U.  Siebenlist,  NIH,  Bethesda,  MD)  (33)  and  ~-actin 
cDNA (P.E. Auron, Harvard Medical School, Boston, MA) were 
labeled with  [32p]dCTP  and subsequent Northern  blot  analysis 
was performed. 
ELISA  Assay  of MIP-I~3  in  Supernatant  or  Cytosol  of ATL 
Cells.  Freshly obtained normal T  cells and ATL cells (106) were 
washed in PBS  and lysed with 250 }xl of PBS  containing 2% 
N-octyl-~-D-glucopyraide (Sigma).  The culture supernatants were 
collected from normal T  cells (10 6) and ATL cells  (106) after the 
24-h incubation in RPMI  1640 with 5% FCS at 37°C without 
any stimulation. The MIP-113 protein levels in each sample were 
measured by MIP-I[~ ELISA system (R&D Systems, Minneapo- 
hs, MN). The sensitivity of the assay is 4.0 pg/ml of MIP-113 and 
it was not affected by the presence of N-octyl-J3-D-glucopyraide 
at the concentration used to lyse cells.  Results were expressed in 
nanograms per milliliter per 105 cells. 
Immunofluorescence Staining of Cell  Surface Heparan  Sulfate and 
MIP-I~.  Freshly obtained ATL  cells and ATL cell line MT1 
were cultured with or without 1 mM NAP-D-xyloslde for 5 h at 
37°C or were treated with the mixture of 100 mU/ml heparitl- 
nase I and II for 2 h at 37°C. After putting the cells on glass slides 
by cytospin,  indirect immunofluorescence was  performed  with 
anti-heparan  sulfate  mAb  HK249  and  PE-conjugated  anti-rat 
IgG (Fujisawa)  or anti-MIP-lJ3 Ab (U. Siebenlist) (33) and FITC- 
conjugated anti-rabbit IgG (Fujisawa). The staining was analyzed 
with a  fluorescence macroscope  (Epl-fluorescence Condense IV 
FI; Zeiss, Oberkochen, Germany). 
Results 
A TL  Cells and  Cell Lines  Sponta~wously Adhered  to HUVEC. 
ATL is a characteristic leukemia which shows a marked in- 
crease  of peripheral ATL cells and their severe  infiltration 
into multiple organs in an acute phase  (22-24).  Leukocyte 
migration from  circulation into  tissue  depends  on leuko- 
cyte  integrin-mediated adhesion  to  endothelial  cells.  Be- 
cause  leukocyte  integrins cannot function until activated, 
the regulation of integrin-dependent adhesion is critical to 
the migration of virtually all the hematopoietic cells (1, 3). 
For instance, as shown in Fig.  1,  resting peripheral T  cells 
did  not bind to  IL-l-activated  HUVEC,  whereas  T  cells 
activated with PMA,  which is one potent integrin trigger, 
adhered to them well.  CD4-positive leukemic cells from a 
patient with HTLV-I-negative T  cell leukemia also did not 
brad  to  HUVEC.  However,  both  ATL  cells  freshly  ob- 
tained  from  three  representative  ATL  patients  and  four 
ATL  cell  lines,  MT1,  MT2,  SALT-3,  and  HUT-102, 
spontaneously bound to  HUVEC  without  any exogenous 
stimuli after the 30-min incubation. 
A TL  Cells and  Cell Lines  Expressed Activated  LFA-1  and 
Heparan  Sulfate  on the Cell Surface.  Leukocyte  selectins  and 
integrins mediate its adhesion to endothelial cells (1). Next, 
we  assessed the  expression of these  adhesion molecules on 
freshly obtained ATL cells using a flow cytometer (Fig. 2). 
Although it was  assumed that  ATL cells (Fig.  2,  group  B) 
might express  these adhesion molecules more than normal 
T  cells  (Fig.2,  group  A),  integrin LFA-1  and  CD2  were 
equally expressed  on ATL cells with normal CD4 +  T  cells 
(Fig. 2, b and d) and L-selectin and VLA-4 were rather de- 
creased on ATL cells compared with CD4 ÷ T  cells (Fig. 2, 
a  and  c).  However,  it  Is  of interest  that  NKI-L16  rnAb 
which  binds to  functionally activated  LFA-1  (26,  34)  re- 
acted significantly highly with most of the freshly obtained 
ATL  cells,  compared  with  resting  CD4 +  normal  T  cells 
(Fig.  2  e).  The  mean fluorescence  intensity for  NKI-L16 
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Figure 2.  Phenotypic  analysis of fresh ATL cells by flow 
cytometer.  Stalmng  and  flow  cytomemc  analyses of 10 
resting  peripheral  normal  CD4  +  T  cells (group  A)  and 
ATL cells freshly obtained  from periphery  of 18 ATL pa- 
nents  (group  B)  were  carried  out  wtth  (a)  L-selectln 
(CD62L)  mAb Leu-8,  (b)  LFA-1  (CDlla) mAb TS1/22, 
(c)  VLA-4  (CD49d)  mAb  N1H49d-1,  (d)  CD2  mAb 
MAR206, (e) anuactivated form ofLFA-1 mAb NKI-L16, 
(f)  ann-heparan  sulfate mAb  HK249  using  FACScan  ® 
Each point shows the percent posmvlty  of the binding  of 
indicated mAbs compared w, th control *nAb Thyl.2 from 
individual persons  The bars ln&cate mean  -+ SD of each 
group  and the asterisks show an  overall stansncal s, gmfi- 
cance of P <0 01 (Student's t test). 
staining  was  also  higher  in  ATL  cells  than  that  in  normal 
CD4 +  T  cells  (285  -+  79  vs.  146  -+  31,  P  <0.01  by  Stu- 
dent's t test). All the ATL cells also expressed MHC  class II 
antigens,  CD25  and  CD69,  regarded  as activation markers 
(data not shown).  The results  suggest that  spontaneous  ad- 
hesion  of ATL  cells  to  endothelium  depends  on  already 
triggered/activated integrins rather than the quantity of the 
integrins expressed on ATL cells. 
Furthermore,  it is worthy  of note  that  all the ATL  cells 
and cell lines expressed heparan  sulfate proteoglycan on the 
cell surface detected by HK249 mAb, which possesses sharp 
specificity for tumor type (O-sulfate deficient) heparan  sul- 
fate chains  (25),  but resting T  cells did not at all (Fig.  2f). 
As far as we have done,  none  of both resting and cytokine 
or  lectin-activated  cells  from  hematopoietic  origin  ex- 
pressed  the heparan  sulfate  (data  not shown).  The  heparan 
sulfate on one representative ATL patient and ATL cell hne 
MT1  was  also  detected  by  another  anti-heparan  sulfate 
mAb  10E4  (Fig.  3,  B  and E).  The  expression was reduced 
by the pretreatment of ATL cells or MT1  with the mixture 
of 100 mU/ml  heparitinase  I  and II for 2  h  at 37°C (Fig. 3, 
C  and  F),  whereas  the  expression  of LFA-1  on  ATL  cells 
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Figure 3.  Expression  of hepa- 
ran  sulfate on  ATL  cells and 
ATL cell hne MT1. The expres- 
sion  of heparan  sulfate on ATL 
cell hne  MT1  (A,  B,  C,  G,  H, 
and  /)  and  one  representative 
ATL patient  (D-F) which were 
pretreated  with (C,  F, and /) or 
without (B, E, and H)  the rmx- 
ture  of 100 mU/ml hepantinase 
I and II for 2 h at 37°C was de- 
tected  by  antx-heparan  sulfate 
mAb  10E4 (B,  C,  E,  and  F)  or 
anU-LFA-1  (CD11a)  mAb TS1/ 
22 (H,/) using FACScan ®. y-axis 
represents  the  histogram  of cell 
number  stained  with  mAbs  an 
each loganthrmc  scale of fluores- 
cence  amphfier.  Thyl.2  mAb 
was used as a neganve  control  of 
the staining (A, D, and G). 
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Figure 4.  Spontaneous  MIP-113  retiNA transcription on ATL cells and 
cell lines. For the Northern blot analysis, total cellular P,  NA was isolated 
from HUT-102  (lane a) and MT2 (lane b), three representative ATL pa- 
tients (lanes c-f), and normal CD4 + T cells (lanes g and h) and Northern 
blot analysis was performed using pAT 744 MIP-lJ3 cDNA and J3-actm 
cDNA. 
was not affected by the treatment  (Fig.  3, H  and/).  Thus, 
different from any hematopoietic  cells which we have  ex- 
amined,  ATL  cells  characteristically  and  specifically  ex- 
pressed heparan sulfate proteoglycan on their surface. 
A TL  Cells and  Cell  Lines  Spontaneously  Produced Chemo- 
kineMIP-l~.  We  and  others  have  reported  that  ATL 
cells  produce  multiple  cytokines  including  IL-1,  IL-6,  and 
TNF-0¢  (35-37).  ATL  cell  lines  MT2  and  HUT-102  and 
four  representative  freshly  obtained  ATL  cells  spontane- 
ously  synthesized  large  amounts  of MIP-I[3  mP,  NA  by 
Northern blot analysis, whereas normal T  cells  did not (Fig. 
4). Furthermore, freshly obtained ATL cells from periphery 
of  the  patients  produced  significantly  high  amounts  of 
MIP-I[3 proteila in the culture supernatant as well as in the 
cytosol without any stimulation,  compared with normal T 
cells  (Fig.  5).  MIP-I[3 is  a  member  of chemokine  family 
which is now understood to trigger leukocyte integrin and 
to induce its adhesion, e.g., MIP-I[3 and MIP-lot for T  cell 
subsets  and  IL-8  for  neutrophils  (6,  9,  38),  all  of which 
were also produced by ATL cells  (data not shown).  Thus, 
ATL  cells  spontaneously  produced  multiple  proadhesive 
chemokines. 
MIP- I~  Was Expressed on the Su~ace ~  A TL Cells and Its 
Expression  Was Reduced by the Interruption of Heparan Sulfate- 
Proteoglycan Synthesis.  As shown in Fig.  6 A, heparan sul- 
fate  was strongly detected  on ATL cell line MT1,  by im- 
munofluorescence staining using anti-heparan  sulfate mAb 
HK249. Of note is that MIP-1 [3 was also comparably stained 
with anfi-MIP-l[3 Ab on the surface of not only MT1  (Fig. 
6 D) but also fleshly obtained ATL cells  (Fig.  6  G). Chemo- 
kines  including MIP-I[3 possess  heparin-binding  sites  (39) 
and we and others have proposed that cell surface heparan 
sulfate proteoglycan immobilizes chemokine (6,  8-10).  In- 
terestingly,  when MT1  or ATL cells  were pretreated  with 
the mixture of 100 mU/ml heparitinase  I and II for 2 h, the 
expression of MIP-l[3 as well as heparan sulfate on the sur- 
face was markedly reduced (Fig.  6,  B, E,  and H).  Further- 
more, pretreatment of  MT1 and ATL cells with 1 mM NAP- 
D-xyloside  for  5  h  which  interrupts  endogenous  heparan 
sulfate proteoglycan biosynthesis (30, 31, and manuscript in 
preparation),  resulted in suppression of cell surface MIP-1 [3 
(Fig.  6, F and/). These results indicate that ATL cell-derived 
MIP-I[3 appeared  to  be  retained  on the  ATL cell  surface 
through binding to heparan  sulfate  chains  of proteoglycan 
expressed on ATL cells. 
Heparan Sulfate Was Involved in the Spontaneous Adhesion  of 
ATL Cells.  Finally,  we  assessed  if the  heparan  sulfate  is 
involved  in  the  spontaneous  adhesion  of ATL  cells  and 
MT1  to  HUVEC.  MT1  (Fig.  7  A)  and  freshly  obtained 
ATL  cells  (Fig.  7  B)  without  stimulation  and  PMA-acti- 
vated peripheral normal T  cells  (Fig. 7  C) adhered to [L-I- 
activated  HUVEC  well.  However,  when  MT1  and  ATL 
cells  were  pretreated  with  NAP-D-xyloslde,  the  adhesion 
was inhibited in a concentration-dependent manner, whereas 
its nonfunctional isomer NAP-L-xyloside did not affect the 
adhesion  (Fig.  7, A  and  B).  Neither  NAP-D-xyloside nor 
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Figure  5.  Spontaneous MIP-I[3 producuon 
from ATL cells. The cytokme levels in cytosol 
(A)  of normal CD4  + T  cells (group A)  and 
ATL cells fleshly obtained from periphery of 
ATL patients (group B) or culture supernatants 
(B)  collected from the  normal CD4 + T  cells 
(group A) or the ATL cells (group B) after the 
24-h incubation at 37°C without any snmula- 
tlon were deterrmned by MIP-I~ ELISA sys- 
tem. Each point shows the quanuty of MIP-l~ 
m the lysate or the supernatant derived from 105 
cells of individual persons. The  bars m&cate 
mean  -  SD  of each group and  the  asterisks 
show an overall staustlcal slgmficance  of P <0.01 
(Student's t test). 
1991  Tanaka et al. Figure 6.  Expression ofheparan sulfate and MIP-I[3 on ATL cells and MT1 subjected to xyloslde lnterrupnon ofheparan sulfate proteoglycan bmsyn- 
thesis and enzymatic  &gestion  ofheparan sulfate chains. MT1 (A-F) and fresh ATL cells from one representative patient  (G-/) were cultured without 
(A, D, and G) or with 1 mM NAP-D-xyloslde for 5 h at 37°C (B, E, and/4) or were treated with the mixture of 100 mU/rnl heparltlnase I and II for 2 h 
at 37°C (C, F, and/).  Indxrect immunofluorescence  was performed wxth anti-heparan  sulfate mAb HK249 and PE-conjugated  ann-rat IgG (A-C) or 
antx-MIP-l[~ Ab and lqTC-conjugated antl-rabbat IgG (D-/) and the expression was observed by fluorescence microscopy (× 1,000). 
NAP-t-xyloside  affected  the  adhesion  of PMA-activated 
normal  T  cells,  which  did  not  express  heparan  sulfate  to 
HUVEC  (Fig. 7  C). 
MT-1  also  spontaneously  adhered  to  purified  ICAM-1, 
an endothelial ligand for the integnn LFA-1  and it was in- 
hibited by the pretreatment with NAP-D-xyloside, whereas 
neither NAP-l-xyloside nor HEX-D-xyloside did affect the 
adhesion  (Fig. 8).  Furthermore,  both the adhesion  of MT1 
to purified ICAM-1 (Fig. 8 A) and to IL-l-activated HUVEC 
(Fig.  8  B)  was  reduced  by  the  pretreatment  of MT1  with 
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Figure 7.  The effect of partxcular  xyloslde 
on the adhesxon of ATL cells and MT1  to 
IL-l-activated  HUVEC.  (A)  MT1,  (B) 
fresh  ATL  cells, and  (C)  PMA-acUvated 
normal  T  cells were  premcubated  with or 
without  m&cated concentration  of NAP- 
D-xylomde (dense line) or NAP-t-xyloside (dot- 
ted line)  for 5 h at 37°C and adhesion assay 
of obtained cells to IL-l-actwated HUVEC 
was  performed  as in Fig.  1.  Data  are  ex- 
pressed as mean percentage ofbm&ng ofln- 
&cated  cells from  a representauve  expen- 
ment. 
1 Ixg/ml pertussis toxin, ADP  ribosylates which  uncouple 
certain G-protein from its complex, mAb-blocking studies, 
in which MTl-adhesion to ICAM-1  or activated HUVEC 
was inhibited by anti-LFA-1/VLA-4 mAbs or anti-LFA-1 
mAb (10  Ixg/ml), respectively, indicated that the adhesion 
was  mediated  by ATL  cell integrins and their  endothelial 
ligands. Thus, the results suggested that heparan sulfate was 
involved in integrin-mediated adhesion of ATL cells to en- 
dothelial integrin ligands, which might be activated through 
G-protein. 
Discussion 
The cell surface heparan sulfate in the form ofproteogly- 
can is known  to immobilize heparin-binding cytokines or 
growth factors,  affecting cell growth/adhesion  and modu- 
lating clinically relevant  events  such  as  inflammation and 
tumor metastasis  (11,  14,  18).  Here  we  demonstrate three 
pivotal points for  the  mechanisms of how  heparan  sulfate 
amplifies  leukemic  cell  adhesion  to  endothelium,  using 
ATL cells, which show a spontaneous adhesion to HUVEC 
in vitro and a  tendency of severe infiltration into tissue in 
vivo: (a)  suitable heparan sulfate is expressed on ATL cells, 
whereas  none  of resting and activated  cells from hemato- 
poietic  origin  do  express  heparan  sulfate;  (b)  cell  surface 
heparan sulfate immobilizes integrin-triggering chemokine 
on ATL cells,  since the  expression of cell surface  chemo- 
kine is abolished by xyloside-induced interruption ofhepa- 
ran sulfate-proteoglycan biosynthesis or by heparitinase di- 
gestion of cell surface-associated heparan sulfate chains; and 
(c)  the  artificially decreased  cell surface  heparan  sulfate re- 
suits in the integrin-mediated adhesion of ATL cells to en- 
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Figure  8.  The  adhesion  of 
MT1 to IL-l-acUvated HUVEC 
and purified  ICAM-1. The ad- 
hesion  assay of  MT1  which 
were pretreated  with or without 
1 mM  NAP-D-xylosxde, NAP- 
L-xyloside, HEX-D-xyloslde or 1 
I~g/ml pertussxs toxin to (A) pu- 
rafted ICAM-1 or (B) IL-l-acti- 
rated  HUVEC  was  carried  out 
in the presence or absence ofin- 
&cated  adhesxon-blockmg mAbs 
(10  I.tg/ml). Data  are  expressed 
as mean percentage of binding of 
in&cated cells from a representa- 
tive expenment. 
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Figure 9.  Diagram  showing the slgmficance  of heparan sulfate m ATL 
cell mfiltratmn. We propose that heparan sulfate on ATE cells immobi- 
lizes heparin-blnchng chemokme MIP-I~ derwed from ATL cells, by 
which ATL cell mtegnns are efficxently  triggered to adhere to hgands on 
endothehum 
dothelial cells and purified ICAM-1. Thus, we propose that 
heparan  sulfate proteoglycan  on  the  surface  of ATL  cells 
can be involved in integrin triggering and the cellular adhe- 
sion  to  endothelial  ligands  through  immobilizing chemo- 
kines (Fig. 9). 
Although  the  relevance  of cell  surface  heparan  sulfate 
proteoglycan  to  heparin-binding  cytokines  is  emerging 
(13-17),  it was  difficult to investigate the involvement of 
heparan sulfate in cellular functions. It has been considered 
that  suitable  xylosides  as  well  as  heparitinases  should  be 
useful  to  perform  these  studies.  We  newly  developed 
NAP-D-xyloside, which appears to be appropriate for func- 
tional assessments ofheparan sulfate proteoglycan, since this 
compound,  but  not  its  t-isomer,  is  capable of interrupting 
endogenous heparan sulfate- and chondroitin sulfate-pro- 
teoglycan  biosynthesis  in  cytoplasmic  organdie  such  as 
Golgi bodies and also can inhibit the immobilization ofhe- 
parin-binding  cytokines  there  in  advance  to  posting  and 
transferring  them  to  the  cell  surface  (16,  40).  Actually, 
NAP-D-xyloside inhibited not only the chemokine expres- 
sion on the ATL cell surface but also the integrxn-mediated 
adhesion through triggering by the posting chemokines. Fur- 
thermore, the control, NAP-L-xyloside, and HEX-D-xylo- 
side,  which  selectively interrupts  chondroitin  sulfate-pro- 
teoglycan synthesis,  did not affect the chemokine expression 
and  integrin-mediated  adhesion  of ATL  cells.  Thus,  the 
newly established xyloslde would allow us to execute pre- 
cise  functional Investigations in the contexts with heparan 
sulfate on cellular functions. 
It is becoming clearer that the heparan sulfate proteogly- 
can expressed on cellular surface is connected to cytokine 
network by their own bioactive functions  as indicated  by 
the following: (a) cell surface heparan sulfate interacts with 
basic  FGF  to  facilitate their interaction  with  high  affinity 
receptors on fibroblasts in an autocrine mechanism (41);  (b) 
heparan  sulfate on stromal cells  in  the bone marrow pre- 
sents IL-3 and GM-CSF to myeloid progenitors m  a para- 
crine  mechanism (17);  (c) heparan  sulfate on vessels  binds 
and presents not only chemokines such as MIP-I[3 and IL-8 
but also hepatocyte growth factor to passing (tethering) leu- 
kocytes without being washed away by the blood flow in a 
juxtacrine system as proposed by us and others (6, 8, 9, 38, 
43).  The  concept  that  heparan  sulfate  proteoglycan  can 
bind/hold and present/relay cytokines to the specific recep- 
tors  and  can induce  cellular function  have come into  the 
involvement of heparan  sulfate  on  ATL  cells  in  chemo- 
kine-mediated  integrin  triggering.  ATL  cells  produced  a 
high  quantity  of chemokine MIP-lJ3  and  the  chemokine 
induced  the  integrin-mediated  adhesion.  The  chemokine 
receptor is known to be a "serpentine" receptor with seven 
transmembrane domains and is a GTP-binding protein which 
is involved in integrin triggering (43-45).  The results that 
pertussis toxin inhibited the integrin-mediated adhesion of 
ATL cells, but not PMA-activated T  cell adhesion, and de- 
creased the  expression of the  activated form of LFA-1  on 
ATL cells  recognized by the  NKI-L16 mAb  (manuscript 
in  preparation)  suggest  that  MIP-I[3  transduced  signaling 
through certain G-protein by the binding to its serpentine 
receptor in an autocrine mechanism. The autocrine mech- 
amsm of the chemoklne mediated by heparan sulfate pro- 
teoglycan would  be  emphasized  in  circulating  leukocytes 
or leukemia cells.  Heparan  sulfate proteoglycan is known 
to  be  synthesized  and  to  bind  any heparin-binding  cyto- 
kines  in  the  cytoplasmic organelles  such  as  Golgi  bodies 
and to be transferred to the cell surface holding the cyto- 
klnes  (16,  40).  Once  "free" chemokines are secreted into 
the circulation,  they would be washed away by the blood 
flow.  However,  by  the  binding  to  the  heparan  sulfate, 
chemokine could be practically accumulated on the cellular 
surface and be presented to the particular chemokine receptor 
in an autocrine mechanism efficaciously.  Alternatively, it can 
he interpreted that the competitive interruption of heparan 
sulfate-proteoglycan  synthesis  by  NAP-D-xyloside  might 
reduce the binding of leukemic heparan sulfate to endothe- 
lial  heparin-binding  molecules  such  as  CD31.  However, 
the adhesion of ATL cells to purifed ICAM-1 which does 
not have heparin-binding sites was also inhibited by the re- 
duction of heparan sulfate synthesis equally to the adhesion 
of  ATL cells to HUVEC. Thus, we propose here that heparan 
sulfate proteoglycan can be involved in chemokine-medi- 
ated autocrine mechanisms in the circulating leukemia cells. 
1994  Heparan Sulfate in Leukemic Cell Adhesion The spontaneous production of MIP-I[3  might be a char- 
acteristic  feature  of  ATL  cells,  since  the  HTLV-I  viral 
product tax induces MIP-113  (46).  However,  as described, 
ATL  cells  produce  multiple  cytokines  including  heparin- 
binding chemokines in addition to MIP-I[3, and anti-MIP- 
113  Ab  only  slightly  inhibited  the  adhesion  of ATL  cells 
(data not shown), suggesting that MIP-1I~ is one represen- 
tative  chemokine  and  the  involvement of heparan  sulfate 
proteoglycan in ATL cellular adhesion would be generalized 
to the adhesion mediated by multiple chemokines. 
An  adhesion  cascade  consisting of tethering,  triggering, 
and adhesion, has been proposed to explain the mechanism 
of normal leukocyte adhesion to endothelium (1-4, 7, 25). 
The present communication also suggests that this concept 
can  be  expanded  to  leukemic  cell  migration.  Circulating 
ATL  cells  first  tether  to  endothelium  through  the  loose 
tethering of selectin to its ligand such as sialyl Lewis  x, since 
ATL  cells  express  a  high  density  of  sialyl  Lewis  x  (47), 
which can effectively lead to the second step of triggering. 
The trigger appears to be essential for the adhesion of ATL 
cells  similarly  to  leukocytes,  in  which  signal  transduction 
converts the functionally inactive integrin to an active ad- 
hesive configuration through the G-protein by the heparan 
sulfate-immobilized  chemokine.  The  efficient  triggering 
brings high affinity adhesion  of ATL  cells  to  endothelium 
and subsequent infiltration into underlying tissues  (Fig.  9). 
The densities of heparan sulfate on ATL cells varied among 
patients  who  had  different  clinical  features  and  activation 
status.  Several  reports  suggest  that  expression  of heparan 
sulfate depends on the type of tumor cells and that the ac- 
cumulation of cell surface heparan sulfate is correlated with 
metastatic  properties  of some  tumor cells  (11,  48).  It  has 
also been reported that the heparin-binding cytokines such 
as GM-CSF and IL-8 determine the metastatic potential of 
various tumor cells (49, 50). Structural diversity of cell sur- 
face  proteoglycan  in  regard  to  protein  core  and  heparan 
sulfate  chains  may provide  additional  specificity  for cyto- 
kine  immobilization  (39),  and  differential  production  of 
heparin-binding  cytokines  from  tumor  cells  might  pre- 
scribe  ability  of integrin  triggering,  adhesion  to  endothe- 
lium, and metastasis. 
Taken  together,  we  propose  that  cell  surface  heparan 
sulfate  on  circulating  leukemic  cells  can  induce  integrin- 
mediated adhesion through chemokine-mediated autocrine 
mechanisms by posting and relaying chemokine to the re- 
ceptor on the cells.  Heparan sulfate appears to have a junc- 
tional role between cytokines and adhesion molecules, the 
two greatest mediators  of cellular communication.  This  is 
the  first  report  to  explore  the  significance  of interaction 
among heparan  sulfate  proteoglycan  and  heparin-binding 
cytokine for circulating tumor adhesion. Our findings war- 
rant further studies, to see whether different proteoglycans 
and cytokines might bring enormous flexibility to the pro- 
cess of leukemic  cell infiltration and tumor metastasis,  and 
would introduce new pharmacological approaches to con- 
trol them. 
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